Børsen
Disappointing sales of Wegovy initiated a sell-off of Novo Nordisk shares on Wednesday when the company presented its quarterly report. The management points out that this is due to discounts and does not affect growth prospects.
Disappointing sales of Wegovy initiated a sell-off of Novo Nordisk shares on Wednesday when the company presented its quarterly report. The management points out that this is due to discounts and does not affect growth prospects.